BREAKING
Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 8 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 8 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 12 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 13 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 15 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 17 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 19 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 20 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 21 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 21 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 8 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 8 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 12 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 13 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 15 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 17 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 19 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 20 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 21 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 21 hours ago
ADVERTISEMENT
Market News

Boston Scientific Corporation (BSX): Q4 2019 Earnings Snapshot

—  Boston Scientific (NYSE: BSX) reported earnings of $0.46 per share in the fourth quarter of 2019, vs. $0.44 per share expected. — Total revenue grew 13.4% to $2.91 billion, vs. $2.92 billion expected. The revenue growth was spread across all segments and all geographic regions in Q4.   — Expects 10-12% growth in revenues for the fiscal […]

$BSX February 5, 2020 1 min read
Boston Scientific Q4 2019 earnings infographic

—  Boston Scientific (NYSE: BSX) reported earnings of $0.46 per share in the fourth quarter of 2019, vs. $0.44 per share expected.

— Total revenue grew 13.4% to $2.91 billion, vs. $2.92 billion expected. The revenue growth was spread across all segments and all geographic regions in Q4.  

— Expects 10-12% growth in revenues for the fiscal year 2020 on a reported basis. Adjusted EPS for this period is projected in the range of $1.74 to $1.79 per share.

— BSX shares were up 0.75% immediately following the announcement. 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT
ADVERTISEMENT